findmyKOL
Clinical trialNCT06797024RecruitingInterventional

JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders

SponsorTongji HospitalEnrollment20Autoimmune Diseases of the Nervous System
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Tongji Hospital Affiliated To Tongji Medical College of Huazhong University of Science and Technology

    Wuhan, Hubei, China

    Bitao Bu, MDChuan Qin, MDChunrui Li, MDDaishi Tian, MDDi Wang, MDJianfeng Zhou, MDMin Zhang, MDWei Wang, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 2025
Primary completion
31 Dec 2026
Completion
31 Mar 2027
Last update posted
31 May 2025
Registered enrollment
20
Registry id
NCT06797024
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.